^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Somatuline LA (lanreotide suspension intramuscular)

    i
    Other names: BIM 23014, BIM 23014C, BM 23014, ITM-014, ITM-014N
    Associations

    News

    Trials
    Company:
    Ipsen, Teijin
    Drug class:
    Somatostatin analogue
    Related drugs:
    Associations

    News

    Trials
    over3years
    A trial to assess efficacy and safety of octreotide subcutaneous depot in patients with GEP-NET (clinicaltrialsregister.eu)
    P3, N=302, Ongoing, Camurus AB
    New P3 trial
    |
    SSTR (Somatostatin Receptor)
    |
    SSTR positive
    |
    Somatuline Depot (lanreotide prolonged-release subcutaneous) • Oclaiz (octreotide subcutaneous depot) • Somatuline LA (lanreotide suspension intramuscular) • octreotide acetate
    almost4years
    A clinical trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET) Studio clinico finalizzato a valutare il profilo di sicurezza e di attività di cabozantinib in combinazione a lanreotide in tumori neuroendocrini (NET) gastroenteropancreatici (GEP) e toracici (clinicaltrialsregister.eu)
    P2, N=69, Ongoing, FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI"
    Clinical • New P2 trial
    |
    PIAS4 (Protein Inhibitor Of Activated STAT 4)
    |
    Cabometyx (cabozantinib tablet) • Somatuline Depot (lanreotide prolonged-release subcutaneous) • Somatuline LA (lanreotide suspension intramuscular)